drugset / Trial / NCT06255379
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC
Timeline
- Start
- 2024-05-06
- Primary completion
- 2027-03-21
- Completion
- 2027-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fuquinitinib | Unknown | 5 mg | — |
| Subject | Tegafur-Gimeracil-Oteracil | Unknown | 40 mg/m2 | Oral |
| Subject | Tegafur-Gimeracil-Oteracil | Unknown | 50 mg/m2 | Oral |
| Subject | Tegafur-Gimeracil-Oteracil | Unknown | 60 mg/m2 | Oral |